In honor of America’s birthday, “Fast Money” traders pick companies to own that could be around for the next 239 years.» Read More
Delphi Management founder Scott Black says the S&P 500 is already "fully valued," while small- and mid-cap companies are "overvalued."
The stock-moving news flow started early out of the American Society of Clinical Oncology meeting in Chicago.
Legendary trader Laszlo Birinyi sees all the bearish talk from his peers and the media and takes the opposite view.
Markets face a barrage of potential catalysts as the month of June begins, a traditional period of stock market weakness.
Even though the latest GDP report showed a contraction in the economy, the Fed may have to raise rates, analysts says.
Technical analyst Rich Ross explains why the Nasdaq could surge as much as 5 percent this week.
Stifel Financial is in advanced negotiations to acquire Barclays' U.S wealth management unit, according to three people familiar with the situation.
The "Fast Money" traders give their final trades of the day.
June offers bargains on athletic shoes, travel, peaches, and lots more.
Jim Cramer reveals his game plan of stocks and market events he is watching next week. Could the Humana rumors turn into a big deal on Monday?
As a selling wave hit stocks Friday, traders chatted up a market factoid that appeared to lay the blame for the decline on month end maneuvers.
Jim Cramer sees that between Shake Shack and Red Robin there are too many chefs in the kitchen. Should you join the burger war?
Jim Cramer highlights that the U.S. is spending less on our military, but does that mean defense stocks are a lost cause? Maybe not.
Deal chatter heats up, as autos look to shift into high gear, with CNBC's Melissa Lee and the Options Action traders.
Incyte stands to benefit from unveiling data on its cancer treatments at a conference in the coming days, a biotech analyst said.
Professor Jim Cramer is testing you! Miss any of "Mad Money" this week? Get your recap in this quiz and find out if you've earned a Cramerican badge.
A willing oil trade. Why aren't oil stocks rallying? And a bullish trade on Google. With CNBC's Melissa Lee and the Options Action traders.
Independent investment consultant David Darst believes there are three things holding back this "Sleeping Beauty" market.
JP Morgan CEO Jamie Dimon's recent assertion that some bank shareholders are lazy is "ludicrous," bank analyst Mike Mayo said.
It's that time again. With researchers set to convene at the American Society of Clinical Oncology meeting, here are the stocks to watch.